Jean-Paul Borg

23PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Structure and dynamics of materialsPredictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 30, 2026
Prickle and Ror modulate Dishevelled-Vangl interaction to regulate non-canonical Wnt signaling during convergent extension in <i>Xenopus</i>.

|Feb 18, 2026
An inducible multiciliated cell line resolves proteome dynamics and identifies CDK7 as a conserved regulator.

Camille Boutin, Olivier Rosnet, Marine Touret

|Oct 02, 2025
Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery.

Margherita Grattarola, Nicolas Pons, Floriane Cannet

|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Celia Sequera, Margherita Grattarola, Floriane Cannet

|Mar 12, 2025
Dact1 induces Dishevelled oligomerization to facilitate binding partner switch and signalosome formation during convergent extension.

Allyson Angermeier, Deli Yu, Yali Huang

|May 21, 2024
Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer.

Charlotte Dessaux, Laetitia Ganier, Louis Guiraud

Pageof 4

Frequent Collaborators

7 joint publications

Stéphane Audebert

5 joint publications

Luc Camoin

3 joint publications

Michel Aurrand-Lions

3 joint publications

Sudhansu K Dey